NestLens
Portfolio Company

Neurosoft Biologics

Overview

Discover our deeptech vision with a medtech execution, advancing Brain-Computer Interfaces (BCI) through ultra-soft, minimally invasive technology. Learn how our innovative brain interfaces reduce risks like scar tissue and subdural hematomas, while our AI integration enhances data analysis and treatment outcomes for neurological disorders, unlocking new potential in neurotechnology.

Visit website ↗View full profile on NestLens →

Related on NestLens

Last updated July 15, 2026